Take Therapeutic Cloning Forward

What will the US Senate actually do about therapeutic cloning--the procedure of using nuclear transfer to derive embryonic stem cells?

Written byArlene Judith Klotzko
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

What will the US Senate actually do about therapeutic cloning--the procedure of using nuclear transfer to derive embryonic stem cells? The saga continues with the sudden plot changes, reversals of fortune, mischievous machinations, and the cliff-hanger ending worthy of a mystery thriller. The latest twist has not occurred in the Senate itself but in the laboratory. The journal Nature published two reports on stem cells in rodent models that are no less than thrilling to those of us who hope for--and wait for--cures. Ron McKay and his team at the National Institutes of Health have shown that stem-cell therapy actually works.1 In a rat model, mouse embryonic stem cells differentiated into neurons, secreting dopamine, and actually reversed the symptoms of Parkinson disease.

Research by Catherine Verfaillie and her team at the University of Minnesota demonstrates that a certain type of adult bone marrow cell, called MAPC, can differentiate into a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies